Skip to Main Content

Medtronic plc

MDT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

$MDT is featured in our Dan Meuser strategy.

See All Strategies
Income
Balance Sheet
Cash Flow
MDT Income Statement
MDT Balance Sheet
MDT Cash Flow

Recent trades of MDT by members of U.S. Congress

Politician Type Traded
John James House / R Sale $1,001 - $15,000 Sep. 04, 2024
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Aug. 26, 2024
Earl Blumenauer House / D Sale $1,001 - $15,000 Jul. 09, 2024
Kathy E. Manning House / D Sale $1,001 - $15,000 Jul. 02, 2024
John James House / R Purchase $1,001 - $15,000 Jun. 18, 2024
John James House / R Sale $1,001 - $15,000 Jun. 03, 2024
Shelley Moore Capito Senate / R Sale (Full) $1,001 - $15,000 Feb. 09, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jan. 23, 2024
Kathy E. Manning House / D Purchase $15,001 - $50,000 Jan. 23, 2024
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec. 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec. 28, 2023
Jared Moskowitz House / D Sale $1,001 - $15,000 Dec. 28, 2023
Kathy E. Manning House / D Sale $15,001 - $50,000 Dec. 12, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec. 12, 2023
Kathy E. Manning House / D Sale $1,001 - $15,000 Dec. 12, 2023
Debbie Dingell House / D Purchase $15,001 - $50,000 Dec. 05, 2023
John James House / R Purchase $1,001 - $15,000 Nov. 10, 2023
HON. GREG STANTON House / D Sale $1,001 - $15,000 Oct. 24, 2023
HON. GREG STANTON House / D Purchase $1,001 - $15,000 Sep. 26, 2023
Pete Ricketts Senate / R Sale (Full) $50,001 - $100,000 Sep. 21, 2023
Michael Guest House / R Purchase $1,001 - $15,000 Aug. 07, 2023
Pete Sessions House / R Sale $15,001 - $50,000 Jun. 15, 2023
Kathy E. Manning House / D Purchase $1,001 - $15,000 Apr. 28, 2023
Kathy E. Manning House / D Purchase $1,001 - $15,000 Apr. 28, 2023
Tina Smith Senate / D Sale (Full) $100,001 - $250,000 Apr. 05, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Mar. 06, 2023
C. Scott Franklin House / R Sale $50,001 - $100,000 Feb. 15, 2023
Kevin Hern House / R Sale $1,001 - $15,000 Jan. 31, 2023
Daniel S. Goldman House / D Purchase $15,001 - $50,000 Jan. 31, 2023
Bob Gibbs House / R Sale $15,001 - $50,000 Dec. 21, 2022
Dan Sullivan Senate / R Sale (Full) $1,001 - $15,000 Nov. 30, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Oct. 12, 2022
C. Scott Franklin House / R Purchase $1,001 - $15,000 Sep. 13, 2022
C. Scott Franklin House / R Purchase $15,001 - $50,000 Sep. 13, 2022
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Jul. 29, 2022
Alan S. Lowenthal House / D Sale $1,001 - $15,000 Jul. 28, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul. 27, 2022
William R. Keating House / D Sale $1,001 - $15,000 Mar. 29, 2022
John H. Rutherford House / R Sale $1,001 - $15,000 Mar. 16, 2022
Earl Blumenauer House / D Sale $1,001 - $15,000 Mar. 14, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 22, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 18, 2022
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb. 11, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 09, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 03, 2022
Lois Frankel House / D Sale $1,001 - $15,000 Feb. 02, 2022
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Jan. 21, 2022
MDT Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
MDT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
MDT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by MDT's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Extra-cardiovascular pacing by an implantable cardioverter defibrillator Dec. 03, 2024
  • Patent Title: Implantable medical device fixation Dec. 03, 2024
  • Patent Title: Carrying case for controller of patients with vads Dec. 03, 2024
  • Patent Title: Ventricular geometric and hemodynamic control by heart rate modulation in lvad therapy Dec. 03, 2024
  • Patent Title: Detection of hypertension in lvad patients using speed change Dec. 03, 2024
  • Patent Title: Systems and methods for leadless pacing and shock therapy Nov. 26, 2024
  • Patent Title: Tether assemblies for medical device delivery systems Nov. 26, 2024
  • Patent Title: Medical device anchoring apparatus and placement tool Nov. 26, 2024
  • Patent Title: Cardiac pulsed field ablation Nov. 26, 2024
  • Patent Title: Cardiac pulsed field ablation Nov. 26, 2024
  • Patent Title: Extravascular lead designs for optimized pacing and sensing having segmented, partially electrically insulated defibrillation coils Nov. 19, 2024
  • Patent Title: Transcatheter heart valve prostheses Nov. 19, 2024
  • Patent Title: Brain stimulation and sensing Nov. 19, 2024
  • Patent Title: Facilitating trusted pairing of an implantable device and an external device Nov. 12, 2024
  • Patent Title: Input switching in a ventricular intracardiac pacemaker Nov. 12, 2024
  • Patent Title: Electrode position detection Nov. 12, 2024
  • Patent Title: External wireless power transfer coil Nov. 12, 2024
  • Patent Title: Tets coil alignment conditions algorithm Nov. 12, 2024
  • Patent Title: Managing pump speed when power constrained in a fully implanted lvad system Nov. 12, 2024
  • Patent Title: Fluid drug spread-promoting pump Nov. 12, 2024
  • Patent Title: Optimized intrathecal drug delivery Nov. 12, 2024
  • Patent Title: Electrochemical sensor including multiple work electrodes and common reference electrode Nov. 12, 2024
  • Patent Title: Medical assemblies and methods for implantation of multiple medical leads through a single entry Nov. 12, 2024
  • Patent Title: Surgical system and methods Nov. 12, 2024
  • Patent Title: Far field telemetry communication with a medical device during a recharge session where a prior pairing with the medical device may not exist Nov. 05, 2024
  • Patent Title: Assessing intra-cardiac activation patterns Nov. 05, 2024
  • Patent Title: Ecap based control of electrical stimulation therapy Nov. 05, 2024
  • Patent Title: Cost function for response algorithm Nov. 05, 2024
  • Patent Title: Surgical system and methods of use Nov. 05, 2024
  • Patent Title: Stimulation cycling adjustments based on user input Oct. 29, 2024
  • Patent Title: Controlling electrical stimulation based on a sensed stimulation signal Oct. 29, 2024
  • Patent Title: Implantable extravascular electrical stimulation lead having improved sensing and pacing capability Oct. 29, 2024
  • Patent Title: Iris-style crimpers for medical devices Oct. 29, 2024
  • Patent Title: Focal pulsed field ablation devices and methods Oct. 29, 2024
  • Patent Title: Percutaneous atrial and ventricular septal defect closure device Oct. 29, 2024
  • Patent Title: Feedthrough assembly with feature for controlling component position Oct. 22, 2024
  • Patent Title: Determining posture state from ecaps Oct. 22, 2024
  • Patent Title: Socketed portal anchors and methods of using same Oct. 22, 2024
  • Patent Title: Lead orientation detection Oct. 22, 2024
  • Patent Title: Performing one or more pulse transit time measurements based on an electrogram signal and a photoplethysmography signal Oct. 22, 2024
  • Patent Title: 3d printed medical devices including internal shaping Oct. 15, 2024
  • Patent Title: Medical device with braided tubular body Oct. 15, 2024
  • Patent Title: Implantable medical device with drug reservoir volume sensor system Oct. 15, 2024
  • Patent Title: Clamshell iris-style crimper for medical devices Oct. 15, 2024
  • Patent Title: Implantable pump controller Oct. 15, 2024
  • Patent Title: System and method for core-device monitoring Oct. 08, 2024
  • Patent Title: Segmented lead independent electrode control for sensing or adaptive stimulation Oct. 08, 2024
  • Patent Title: Sensing for heart failure management Oct. 08, 2024
  • Patent Title: Medical device recharging based on patient activity Oct. 01, 2024
  • Patent Title: Folded headspace insulator Oct. 01, 2024
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of MDT in WallStreetBets Daily Discussion

MDT News

Recent insights relating to MDT

CNBC Recommendations

Recent picks made for MDT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MDT

MDT Top Shareholders
Shareholder
Shares Held
MDT Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

MDT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view MDT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top